Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (131-140 of 532) with videos related to

Pageof 54
Sort By:
Drug and Alcohol Dependence|November 13, 2010
Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the ratMichael H Baumann, Zakia Williams, Dorota Zolkowska, et al.
The Journal of Experimental Biology|February 1, 1980
Neuroethological studies of freely swimming Aplysia brasilianaK von der Porten, G Redmann, B Rothman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
X-ray crystal structure of the polymerase domain of the bacteriophage N4 virion RNA polymeraseKatsuhiko S Murakami, Elena K Davydova, Lucia B Rothman-Denes
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2007
Bacteriophage N4 virion RNA polymerase interaction with its promoter DNA hairpinElena K Davydova, Thomas J Santangelo, Lucia B Rothman-Denes
Synapse (New York, N.Y.)|July 22, 2004
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic proteinXiaoying Wang, Michael H Baumann, Heng Xu, et al.
Neuropeptides|October 1, 1987
[3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptorsS McLean, K C Rice, R Lessor, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2013
Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesKyle C Schmitt, Richard B Rothman, Maarten E A Reith
Virology|February 1, 1988
Cloning and generation of a genetic map of bacteriophage N4 DNAC Malone, S Spellman, D Hyman, et al.
Blood|October 9, 1999
A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cellsM Dorsch, N N Danial, P B Rothman, et al.
Synapse (New York, N.Y.)|October 26, 1999
Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneityS O Heyliger, C Jackson, K C Rice, et al.
Pageof 54

Showing results (131-140 of 532) with videos related to

Sort By:
Pageof 54
Drug and Alcohol Dependence|November 13, 2010
Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the ratMichael H Baumann, Zakia Williams, Dorota Zolkowska, et al.
The Journal of Experimental Biology|February 1, 1980
Neuroethological studies of freely swimming Aplysia brasilianaK von der Porten, G Redmann, B Rothman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
X-ray crystal structure of the polymerase domain of the bacteriophage N4 virion RNA polymeraseKatsuhiko S Murakami, Elena K Davydova, Lucia B Rothman-Denes
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2007
Bacteriophage N4 virion RNA polymerase interaction with its promoter DNA hairpinElena K Davydova, Thomas J Santangelo, Lucia B Rothman-Denes
Synapse (New York, N.Y.)|July 22, 2004
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic proteinXiaoying Wang, Michael H Baumann, Heng Xu, et al.
Neuropeptides|October 1, 1987
[3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptorsS McLean, K C Rice, R Lessor, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2013
Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesKyle C Schmitt, Richard B Rothman, Maarten E A Reith
Virology|February 1, 1988
Cloning and generation of a genetic map of bacteriophage N4 DNAC Malone, S Spellman, D Hyman, et al.
Blood|October 9, 1999
A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cellsM Dorsch, N N Danial, P B Rothman, et al.
Synapse (New York, N.Y.)|October 26, 1999
Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneityS O Heyliger, C Jackson, K C Rice, et al.
Pageof 54